EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 123 filers reported holding EPIZYME INC in Q1 2019. The put-call ratio across all filers is 1.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -46.9% | 14,841 | +17.0% | 0.00% | 0.0% |
| Q4 2021 | $32,000 | -51.5% | 12,682 | -1.4% | 0.00% | -50.0% |
| Q3 2021 | $66,000 | +312.5% | 12,865 | +576.4% | 0.00% | +100.0% |
| Q2 2021 | $16,000 | -44.8% | 1,902 | -41.9% | 0.00% | 0.0% |
| Q1 2021 | $29,000 | -53.2% | 3,273 | -42.5% | 0.00% | -66.7% |
| Q4 2020 | $62,000 | +463.6% | 5,695 | +530.0% | 0.00% | +200.0% |
| Q3 2020 | $11,000 | -93.3% | 904 | -91.1% | 0.00% | -94.4% |
| Q2 2020 | $163,000 | +1937.5% | 10,179 | +1838.9% | 0.02% | +350.0% |
| Q1 2020 | $8,000 | +100.0% | 525 | +67.2% | 0.00% | +100.0% |
| Q1 2019 | $4,000 | – | 314 | +946.7% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 30 | -98.4% | 0.00% | -100.0% |
| Q1 2018 | $34,000 | +3300.0% | 1,899 | +4120.0% | 0.02% | +1700.0% |
| Q4 2017 | $1,000 | -75.0% | 45 | -79.0% | 0.00% | -66.7% |
| Q3 2017 | $4,000 | – | 214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |